1-3 of 3
Zhongyu Shi
Close
Sort by
Journal Articles

Preliminary Safety and Efficacy Results of EDI001: An Investigator Initiated Trial on CRISPR/Cas9-Modified Autologous CD34 + Hematopoietic Stem and Progenitor Cells for Patients with Transfusion Dependent β-Thalassemia

Jun Shi, Riguo Fang, Zhen Gao, Zhongyu Shi, Zhexiang Kuang, Yongjian Zhang, Lele Zhang, Huihui Yang, Yingchi Zhang, Dehui Zou, Liwei Fang, Jiali Sun, Qiang Li, Yao Zou, Hong Pan, Jingyu Zhao, Liyun Li, Xiao Yu, Jing Xu, Chun Xu, Yanjie Liu, Weiwei Wang, Jia Shi, Jie Liu, Jia Wang, Nian Shi, Lei Yang, Weiqiang Wang, Suyi Li, Moye Shi, Xiaoshuang Zhang, Pengfei Yuan, Wensheng Wei, Dong Wei, Tao Cheng
Journal: Blood
Blood (2022) 140 (Supplement 1): 10652–10653.
https://doi.org/10.1182/blood-2022-166365
Published: 2022
Journal Articles

CD66e Enrichment Enhances Repopulation of Human Long-Term Hematopoietic Stem Cells

Kuiying Ma, Riguo Fang, Lingling Yu, Yongjian Zhang, Chao Li, Zhongyu Shi, Huihui Yang, Penghui Xia, Xijuan Zhang, Wei Zhang, Pengfei Yuan, Dong Wei
Journal: Blood
Blood (2021) 138 (Supplement 1): 2156.
https://doi.org/10.1182/blood-2021-148235
Published: 2021
Journal Articles

Microtubule Polymerization Inhibition Enhances Human Hematopoietic Stem Cell Homing and Engraftment

Kuiying Ma, Riguo Fang, Lingling Yu, Chao Li, Zhongyu Shi, Huihui Yang, Penghui Xia, Xijuan Zhang, Yongjian Zhang, Wei Zhang, Pengfei Yuan, Dong Wei
Journal: Blood
Blood (2021) 138 (Supplement 1): 3820.
https://doi.org/10.1182/blood-2021-149294
Published: 2021